Home Careers Contact us Print ABOUT US PRODUCT PIPELINE RESEARCH AND TECHNOLOGY PARTNERING INVESTORS MEDIA Home> About us> Strategy About us Company overview Strategy Our vision Senior Leadership Board of Directors History RELATED LINKS Antibody discovery Products in development Licensing opportunities Strategy Our Three-pronged Strategy Focus on core competence Identify the best disease targets Develop unique best-in-class or first-in-class antibodies Develop next generation technologies Turn science into medicine – into real value Generate differentiated antibody therapeutics with significant commercial potential Build a profitable and successful biotech Maintain a flexible and capital efficient model Maximize relationships with partners Retain ownership of select products About us Product pipeline Partnering Research and technology Investors Media Careers Contact us Accessibility policy Cookie policy Disclaimer Sitemap © 2016 Genmab A/S